Extendicare Beheer

Beheer criteriumcontroles 4/4

De CEO Extendicare is Michael Guerriere, benoemd in Oct2018, heeft een ambtstermijn van 6.08 jaar. De totale jaarlijkse vergoeding van { bedraagt CA$ 1.81M, bestaande uit 33.1% salaris en 66.9% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.31% van de aandelen van het bedrijf, ter waarde CA$ 2.69M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 2.2 jaar en 7.9 jaar.

Belangrijke informatie

Michael Guerriere

Algemeen directeur

CA$1.8m

Totale compensatie

Percentage CEO-salaris	33.1%
Dienstverband CEO	6.1yrs
Eigendom CEO	0.3%
Management gemiddelde ambtstermijn	2.2yrs
Gemiddelde ambtstermijn bestuur	7.9yrs

Recente managementupdates

Recent updates

Analyse CEO-vergoeding

Hoe is Michael Guerriere's beloning veranderd ten opzichte van Extendicare's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Sep 30 2024	n/a	n/a	CA$64m
Jun 30 2024	n/a	n/a	CA$59m
Mar 31 2024	n/a	n/a	CA$35m
Dec 31 2023	CA$2m	CA$600k	CA$34m
Sep 30 2023	n/a	n/a	CA$18m
Jun 30 2023	n/a	n/a	CA$1m
Mar 31 2023	n/a	n/a	CA$3m
Dec 31 2022	CA$2m	CA$600k	-CA$5m
Sep 30 2022	n/a	n/a	-CA$1m
Jun 30 2022	n/a	n/a	CA$6m
Mar 31 2022	n/a	n/a	CA$4m
Dec 31 2021	CA$2m	CA$600k	CA$8m
Sep 30 2021	n/a	n/a	CA$27m
Jun 30 2021	n/a	n/a	CA$59m
Mar 31 2021	n/a	n/a	CA$49m
Dec 31 2020	CA$2m	CA$600k	CA$42m
Sep 30 2020	n/a	n/a	CA$31m
Jun 30 2020	n/a	n/a	CA$2m
Mar 31 2020	n/a	n/a	CA$15m
Dec 31 2019	CA$2m	CA$600k	CA$15m
Sep 30 2019	n/a	n/a	CA$1m
Jun 30 2019	n/a	n/a	CA$4m
Mar 31 2019	n/a	n/a	CA$6m
Dec 31 2018	CA$829k	CA$118k	CA$8m

Compensatie versus markt: De totale vergoeding ($USD 1.30M ) Michael } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de UK markt ($USD 1.46M ).

Compensatie versus inkomsten: De vergoeding van Michael is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Michael Guerriere (60 yo)

6.1yrs

Tenure

CA$1,814,755

Compensatie

Dr. Michael R. Guerriere, MD, MBA, has been the Chief Executive Officer and President at Extendicare Inc. since joined in October 22, 2018. Dr. Guerriere serves as Chairman and Chief Executive Officer of E...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Michael Guerriere	CEO, President & Director	6.1yrs	CA$1.81m	0.31% CA$ 2.7m
David Bacon	Senior VP & CFO	5.6yrs	CA$1.12m	0.15% CA$ 1.3m
Steve Paraskevopoulos	Senior Vice President of ParaMed & CTO	2.2yrs	CA$738.35k	0.052% CA$ 451.6k
John Toffoletto	Senior VP	5yrs	CA$966.91k	0.069% CA$ 594.1k
Matthew Morgan	Chief Medical Officer	4.1yrs	CA$655.99k	0.13% CA$ 1.1m
Joe Belinsky	VP of Information Technology & Chief Information Officer	less than a year	geen gegevens	geen gegevens
Jillian Fountain	Vice President of Investor Relations	6.5yrs	CA$364.43k	0.054% CA$ 468.2k
Danielle Parr	Vice President of Public Affairs	less than a year	geen gegevens	geen gegevens
Kathryn Bradley	Vice President of Corporate Development	1.8yrs	geen gegevens	0.014% CA$ 125.4k
Katie LeMoyne	Senior VP & Chief Human Resources Officer	1.8yrs	geen gegevens	0.027% CA$ 233.6k
Wendy Gilmour	Senior Vice President of Long-term Care Operations	1.8yrs	geen gegevens	geen gegevens
Amie Vahrmeyer	Vice President of Long-Term Care Operations for ON	no data	geen gegevens	geen gegevens

2.2yrs

Gemiddelde duur

Ervaren management: Het managementteam van 0S9E wordt beschouwd als ervaren (gemiddelde ambtstermijn 2.2 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Michael Guerriere	CEO, President & Director	6.7yrs	CA$1.81m	0.31% CA$ 2.7m
Alan Torrie	Independent Chairman of the Board	8.8yrs	CA$210.00k	0.042% CA$ 363.3k
Alvin Libin	Honorary Director	8.8yrs	CA$123.37k	geen gegevens
Seth Goldsmith	Honorary Director	8.8yrs	CA$177.37k	geen gegevens
Samir Manji	Independent Director	5.5yrs	CA$106.00k	0.012% CA$ 103.8k
Aladin Mawani	Independent Director	6.9yrs	CA$110.00k	0.030% CA$ 259.5k
Donna Kingelin	Independent Director	8.8yrs	CA$115.00k	0.0072% CA$ 62.3k
Sandra Hanington	Independent Director	10.3yrs	CA$110.00k	0.048% CA$ 413.1k
Brent M. Houlden	Independent Director	4.5yrs	CA$127.00k	0.026% CA$ 228.4k
Norma Beauchamp	Independent Director	5.5yrs	CA$100.00k	0.0048% CA$ 41.5k

7.9yrs

Gemiddelde duur

69yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 0S9E wordt beschouwd als ervaren (gemiddelde ambtstermijn 7.9 jaar).

Extendicare Beheer

Beheer criteriumcontroles 4/4

Belangrijke informatie

Recente managementupdates

Insufficient new directors

Extendicare Inc. Announces Alan Hibben Not Been Re-Elected as A Director

Insufficient new directors

Extendicare Inc., Annual General Meeting, May 23, 2024

Insufficient new directors

Insufficient new directors

Recent updates

Extendicare Inc. Declares Cash Dividend, Payable on December 16, 2024

Dividend of CA$0.04 announced

Extendicare Inc. Declares Cash Dividend for the Month of October 2024, Payable on November 15, 2024

Extendicare Inc. to Report Q3, 2024 Results on Nov 12, 2024

Dividend of CA$0.04 announced

Extendicare Inc. Announces Cash Dividend for the Month of September 2024, Payable on October 15, 2024

Insufficient new directors

Extendicare Inc. Announces July 2024 Cash Dividend, Payable on August 15, 2024

Extendicare Inc. to Report Q2, 2024 Results on Aug 12, 2024

Extendicare Inc. Declares Cash Dividend for the Month of June 2024, Payable on July 15, 2024

Extendicare Inc. Announces Alan Hibben Not Been Re-Elected as A Director

Dividend of CA$0.04 announced

Insufficient new directors

Extendicare Inc. Declares Cash Dividend for the Month of May 2024, Payable on June 17, 2024

Extendicare Inc., Annual General Meeting, May 23, 2024

Extendicare Inc. Declares Cash Dividend for the Month of April 2024, Payable on May 15, 2024

Extendicare Inc. to Report Q1, 2024 Results on May 15, 2024

Upcoming dividend of CA$0.04 per share

Dividend of CA$0.04 announced

Extendicare Inc. Declares Cash Dividend for the Month of March 2024, Payable on April 15, 2024

Full year 2023 earnings released: EPS: CA$0.40 (vs CA$0.051 loss in FY 2022)

Upcoming dividend of CA$0.04 per share

Dividend of CA$0.04 announced

Extendicare Inc. Declares Cash Dividend for the Month of February 2024, Payable on March 15, 2024

Upcoming dividend of CA$0.04 per share at 6.7% yield

Extendicare Inc. to Report Q4, 2023 Results on Mar 07, 2024

Insufficient new directors

Insufficient new directors

Extendicare Inc. Declares Cash Dividend for the Month of December 2023, Payable on January 15, 2024

Extendicare Inc. Declares Cash Dividend for the Month of November 2023, Payable on December 15, 2023

Extendicare Inc. Declares Cash Dividend for the Month of October 2023, Payable on November 15, 2023

Extendicare Inc. to Report Q3, 2023 Results on Nov 09, 2023

Extendicare Inc. Announces Cash Dividend for the September 2023, Payable on October 16, 2023

Insufficient new directors

New minor risk - Profit margin trend

Extendicare Inc. Declares Cash Dividend for the Month of August 2023, Payable on September 15, 2023

Second quarter 2023 earnings released: EPS: CA$0.02 (vs CA$0.039 in 2Q 2022)

Extendicare Inc. (TSX:EXE) completed the acquisition of a 15 percent stake in a Portfolio of 24 Long Term Care Homes from Revera Inc. and Axium Infrastructure Inc.

Insufficient new directors

Extendicare Inc. Declares Cash Dividend for the Month of July 2023, Payable on August 15, 2023

Extendicare Inc. to Report Q2, 2023 Results on Aug 10, 2023

Extendicare Inc. Declares Cash Dividend for the Month of June 2023, Payable on July 17, 2023

Independent Director recently bought CA$108k worth of stock

Upcoming dividend of CA$0.04 per share at 6.6% yield

Senior Vice President of ParaMed & CTO recently bought CA$206k worth of stock

First quarter 2023 earnings released: EPS: CA$0.14 (vs CA$0.045 in 1Q 2022)

Full year 2022 earnings released: CA$0.051 loss per share (vs CA$0.10 profit in FY 2021)

Extendicare Inc. Declares Dividend for the Month of February 2023, Payable on March 15, 2023

Upcoming dividend of CA$0.04 per share

Extendicare Inc. to Report Q4, 2022 Results on Mar 02, 2023

Extendicare Inc. Declares Cash Dividend for the Month of January 2023, Payable on February 15, 2023

Extendicare Inc. Declares Cash Dividend for the Month of December 2022, Payable on January 16, 2023

Independent Director recently bought CA$151k worth of stock

Saskatchewan Health Authority acquired Ownership and operations of five Saskatchewan LTC homes from Extendicare Inc. (TSX : EXE) for CAD 13.1 million.

Extendicare Inc. Declares Dividend for the Month of November 2022, Payable on December 15, 2022

Extendicare Inc. Declares Cash Dividend for the Month of October 2022, Payable on November 15, 2022

Extendicare Inc. to Report Q3, 2022 Results on Nov 10, 2022

Extendicare Inc. Announces Dividend for the Month of September 2022, Payable on October 17, 2022

Extendicare Inc. Declares Cash Dividend for the Month of August 2022, Payable on September 15, 2022

Extendicare Inc. Declares Cash Dividend for the Month of July 2022, Payable on August 15, 2022

Extendicare Inc. to Report Q2, 2022 Results on Aug 09, 2022

Extendicare Inc. Declares Cash Dividend for the Month of June 2022, Payable on July 15, 2022

Sienna Senior Living Inc. (TSX:SIA) and Sabra Health Care REIT, Inc. (NasdaqGS:SBRA) completed the acquisition of Portfolio of Eleven Private-Pay Retirement Residences in Ontario and Saskatchewan from Extendicare Inc. (TSX:EXE) for approximately CAD 310 million.

Extendicare Inc. Declares Cash Dividend for May 2022, Payable on June 15, 2022

Extendicare Inc. Declares Cash Dividend April 2022, Payable on May 16, 2022

Extendicare Inc. to Report Q1, 2022 Results on May 12, 2022

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Extendicare Inc. Declares Cash Dividend on Common Shares for the Month of February 2022, Payable on March 15, 2022

Sienna Senior Living Inc. (TSX:SIA) and Sabra Health Care REIT, Inc. (NasdaqGS:SBRA) entered into an agreement to acquire Portfolio of Eleven Private-Pay Retirement Residences in Ontario and Saskatchewan from Extendicare Inc. (TSX:EXE) for approximately CAD 310 million.